Michael Harty (Clare, Independent) | Oireachtas source

FreeStyle Libre is a blood glucose measuring device to help patients manage their diabetes. On 3 April this year, the device was made available to insulin-dependent diabetics between the age of four and 21. It is a new form of technology. Our question is why there is such a restriction. The system, which is attached to the skin, gives real-time readings on blood sugar. It enables patients to individualise the management of their diabetes. It helps them to adjust their treatment, particularly in regard to diet and exercise, and it tailors their treatment to their specific needs. It also gives health professionals and patients valuable information in supervising their treatment. It is cost-effective, reducing the use of expensive blood testing strips and hospital visits, and helps to reduce the emergence of complications of diabetes such as eye disease, kidney disease and heart disease.

I want to ask why this technology is restricted to those age groups between four and 21.

See this speech in context